510(k) K131294
K131294 is an FDA 510(k) premarket notification submitted by Insulet Corporation for the device "OMNIPOD INSULIN MANAGEMENT SYSTEM". The FDA issued a decision of Substantially Equivalent on August 29, 2013. The device falls under product code LZG (Pump, Infusion, Insulin), a Class II device regulated under 21 CFR 880.5725. Insulet Corporation has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 29, 2013
- Date Received
- May 6, 2013
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Pump, Infusion, Insulin
- Device Class
- Class II
- Regulation Number
- 880.5725
- Review Panel
- CH
- Submission Type